Company intelligence / Profile preview
Taxolog, Inc.
Fairfield, New Jersey, United Statestaxolog.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Taxolog, Inc. was a private biotech/pharma company based in New Jersey focused on developing and commercializing novel taxane-based chemotherapeutic agents for cancer treatment. Its lead programs targeted tubulin and aimed at various neoplastic indications. As of early 2025, all known clinical-stage assets have been discontinued or are pending without recent progress or approvals.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (taxane derivatives and tubulin inhibitors)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Taxolog, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taxolog, Inc..